FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3155152251> ?p ?o ?g. }

• W3155152251 endingPage "548" @default.
• W3155152251 startingPage "539" @default.
• W3155152251 abstract "Solid tumors are a common predisposing factor for invasive candidiasis (IC) or candidemia due to IC. Post hoc analysis of patient-level efficacy and safety data from six studies of anidulafungin (with similar protocols/endpoints) in adults with IC/candidemia summarized by past or recent diagnosis of solid tumors. Patients received a single intravenous (IV) dose of anidulafungin 200 mg, followed by 100 mg once daily. After ≥ 5 to ≥ 10 days of IV treatment, switch to oral voriconazole/fluconazole was permitted in all but one study. Time of solid tumor diagnosis was defined as past, ≥ 6; and recent, < 6 months prior to study entry. Primary endpoint: global response of success (GRS) rate at the end of IV therapy (EOIVT). Secondary endpoints included the GRS rate at the end of all therapy (EOT), all-cause mortality, and safety. The GRS rate in the overall population was 73.4% at EOIVT and 65.5% at EOT. Past or recent solid tumor diagnosis did not affect GRS at EOIVT or EOT (past: 75.5% and 71.4%; recent: 72.2% and 62.2%, respectively). All-cause mortality was 14.4% on day 14 and 20.1% at day 28. Most treatment-emergent adverse events were mild/moderate in severity (81.6%). Treatment of IC was effective regardless of the time of solid tumor diagnosis. Data were pooled from six studies: NCT00496197 (first posted on ClinicalTrials.gov on July 4, 2007); NCT00548262 (first posted on ClinicalTrials.gov on October 23, 2007); NCT00537329 (first posted on ClinicalTrials.gov on October 1, 2007); NCT00689338 (first posted on ClinicalTrials.gov on June 3, 2008); NCT00806351 (first posted on ClinicalTrials.gov on December 10, 2008); NCT00805740 (first posted on ClinicalTrials.gov on December 10, 2008). Patients with solid tumor cancers (cancer of internal organs) have increased risk of fungal infections that can spread in the body through the blood. Infection with Candida species, known as invasive candidiasis (IC) (Candida invades the body in places normally free from germs) or candidemia (Candida infection in the blood), can cause severe illness and/or death. Anidulafungin is an antifungal drug recommended to treat IC/candidemia. This post hoc analysis looked at how effective and safe anidulafungin was in adult patients with IC/candidemia with ‘recent’ or ‘past’ history of solid tumors. The analysis included patients diagnosed with cancer less than 6 months before (recent history) or more than 6 months before (past history) they first received anidulafungin. Patients received anidulafungin by injection (intravenously [IV]) into the veins and, for continued treatment, were able to take a different antifungal drug orally. Of 539 patients from six studies, 139 had confirmed IC/candidemia and a history of solid tumors. Approximately 7 out of 10 (72%) patients were cured or no longer had signs of Candida infection at the end of IV anidulafungin treatment. Results were similar in patients with past or recent diagnosis of solid tumors. Treatment side effects reported in approximately 8 out of 10 (82%) patients were mild-to-moderate in severity. This analysis suggests anidulafungin was well tolerated and effective at treating IC/candidemia in patients with solid tumors, whether diagnosed recently or in the past." @default.
• W3155152251 created "2021-04-26" @default.
• W3155152251 creator A5024247476 @default.
• W3155152251 creator A5040794664 @default.
• W3155152251 creator A5061092373 @default.
• W3155152251 creator A5067746762 @default.
• W3155152251 creator A5083214889 @default.
• W3155152251 date "2021-04-23" @default.
• W3155152251 modified "2023-10-16" @default.
• W3155152251 title "Invasive Candidiasis in Patients with Solid Tumors Treated with Anidulafungin: A Post Hoc Analysis of Efficacy and Safety of Six Pooled Studies" @default.
• W3155152251 cites W1485575759 @default.
• W3155152251 cites W1590119161 @default.
• W3155152251 cites W1605428426 @default.
• W3155152251 cites W1948733660 @default.
• W3155152251 cites W1963480501 @default.
• W3155152251 cites W2015795983 @default.
• W3155152251 cites W2021403712 @default.
• W3155152251 cites W2035853279 @default.
• W3155152251 cites W2043992568 @default.
• W3155152251 cites W2055660570 @default.
• W3155152251 cites W2125929679 @default.
• W3155152251 cites W2126319933 @default.
• W3155152251 cites W2126536749 @default.
• W3155152251 cites W2136227603 @default.
• W3155152251 cites W2145047464 @default.
• W3155152251 cites W2149946566 @default.
• W3155152251 cites W2154371486 @default.
• W3155152251 cites W2163845781 @default.
• W3155152251 cites W2216117396 @default.
• W3155152251 cites W2598422593 @default.
• W3155152251 cites W2609337363 @default.
• W3155152251 cites W2622320500 @default.
• W3155152251 cites W2803024259 @default.
• W3155152251 cites W2907549282 @default.
• W3155152251 cites W2948440767 @default.
• W3155152251 cites W2955048664 @default.
• W3155152251 doi "https://doi.org/10.1007/s40261-021-01024-7" @default.
• W3155152251 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8195786" @default.
• W3155152251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33891293" @default.
• W3155152251 hasPublicationYear "2021" @default.
• W3155152251 type Work @default.
• W3155152251 sameAs 3155152251 @default.
• W3155152251 citedByCount "3" @default.
• W3155152251 countsByYear W31551522512021 @default.
• W3155152251 countsByYear W31551522512022 @default.
• W3155152251 countsByYear W31551522512023 @default.
• W3155152251 crossrefType "journal-article" @default.
• W3155152251 hasAuthorship W3155152251A5024247476 @default.
• W3155152251 hasAuthorship W3155152251A5040794664 @default.
• W3155152251 hasAuthorship W3155152251A5061092373 @default.
• W3155152251 hasAuthorship W3155152251A5067746762 @default.
• W3155152251 hasAuthorship W3155152251A5083214889 @default.
• W3155152251 hasBestOaLocation W31551522511 @default.
• W3155152251 hasConcept C126322002 @default.
• W3155152251 hasConcept C143998085 @default.
• W3155152251 hasConcept C16005928 @default.
• W3155152251 hasConcept C197934379 @default.
• W3155152251 hasConcept C203092338 @default.
• W3155152251 hasConcept C2776222947 @default.
• W3155152251 hasConcept C2779020398 @default.
• W3155152251 hasConcept C2779548794 @default.
• W3155152251 hasConcept C2780651595 @default.
• W3155152251 hasConcept C2780690907 @default.
• W3155152251 hasConcept C2908647359 @default.
• W3155152251 hasConcept C535046627 @default.
• W3155152251 hasConcept C67761136 @default.
• W3155152251 hasConcept C71924100 @default.
• W3155152251 hasConcept C99454951 @default.
• W3155152251 hasConceptScore W3155152251C126322002 @default.
• W3155152251 hasConceptScore W3155152251C143998085 @default.
• W3155152251 hasConceptScore W3155152251C16005928 @default.
• W3155152251 hasConceptScore W3155152251C197934379 @default.
• W3155152251 hasConceptScore W3155152251C203092338 @default.
• W3155152251 hasConceptScore W3155152251C2776222947 @default.
• W3155152251 hasConceptScore W3155152251C2779020398 @default.
• W3155152251 hasConceptScore W3155152251C2779548794 @default.
• W3155152251 hasConceptScore W3155152251C2780651595 @default.
• W3155152251 hasConceptScore W3155152251C2780690907 @default.
• W3155152251 hasConceptScore W3155152251C2908647359 @default.
• W3155152251 hasConceptScore W3155152251C535046627 @default.
• W3155152251 hasConceptScore W3155152251C67761136 @default.
• W3155152251 hasConceptScore W3155152251C71924100 @default.
• W3155152251 hasConceptScore W3155152251C99454951 @default.
• W3155152251 hasFunder F4320324041 @default.
• W3155152251 hasIssue "6" @default.
• W3155152251 hasLocation W31551522511 @default.
• W3155152251 hasLocation W31551522512 @default.
• W3155152251 hasLocation W31551522513 @default.
• W3155152251 hasOpenAccess W3155152251 @default.
• W3155152251 hasPrimaryLocation W31551522511 @default.
• W3155152251 hasRelatedWork W1485575759 @default.
• W3155152251 hasRelatedWork W1963480501 @default.
• W3155152251 hasRelatedWork W1971575371 @default.
• W3155152251 hasRelatedWork W1978979987 @default.
• W3155152251 hasRelatedWork W2120834638 @default.
• W3155152251 hasRelatedWork W3118387144 @default.
• W3155152251 hasRelatedWork W3155152251 @default.
• W3155152251 hasRelatedWork W3177833122 @default.

• next